JAMIE STONER: Open Payments
NPI 1568472512 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 36 payments from 10 companies in 2025. Trend: 2023 $320 · 2024 $511 · 2025 $651
Food & beverage: $651
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $224 |
| Alkermes, Inc. | 8 | $136 |
| Otsuka America Pharmaceutical, Inc. | 7 | $120 |
| Lundbeck LLC | 2 | $36 |
| ABBVIE INC. | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: COBENFY, ARISTADA, REXULTI, ABILIFY ASIMTUFII, UZEDY, CAPLYTA, VRAYLAR, INVEGA SUSTENNA.
Industry payments across WV — which companies pay providers there.
